00867.HK
China Medical System Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 11.07
+0.18%Year over year
Reported trailing growth
- Revenue
- +10.0%
- EBITDA
- -13.4%
- EBIT
- -0.8%
- EPS
- -8.8%
- Free cash flow
- -0.4%
- Operating cash flow
- +8.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.5%
- EBITDA
- -21.4%
- EBIT
- -23.7%
- Net income
- -23.0%
- EPS
- -22.5%
- Free cash flow
- -56.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026